These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16821592)

  • 1. Association between single nucleotide polymorphisms of drug resistance-associated genes and response to chemotherapy in advanced ovarian cancer.
    Obata H; Yahata T; Quan J; Sekine M; Tanaka K
    Anticancer Res; 2006; 26(3B):2227-32. PubMed ID: 16821592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas.
    Yakirevich E; Sabo E; Naroditsky I; Sova Y; Lavie O; Resnick MB
    Gynecol Oncol; 2006 Jan; 100(1):152-9. PubMed ID: 16198399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Factors of resistance of ovarian cancer to combined chemotherapy with the use of platinum derivatives].
    Bliumenberg AG; Gorbacheva LB; Gorbunova VA; Kozachenko VP; Lankin VZ
    Biull Eksp Biol Med; 1996 Dec; 122(12):651-4. PubMed ID: 9280465
    [No Abstract]   [Full Text] [Related]  

  • 4. [Expression and prognostic value of the drug resistance markers P-gp, Mrp1, Mrp2, and Lrp in ovarian carcinoma].
    Katsaros D; Fracchioli S; Arts HJ; de Vries EG; Danese S; Richiardi G; Arisio R; Gordini G; Van der Zee AG; Suurmeijer AJ; Massobrio M
    Minerva Ginecol; 1999 Dec; 51(12):463-70. PubMed ID: 10767994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of chemotherapy resistance genes in outcome of neuroblastoma.
    de Cremoux P; Jourdan-Da-Silva N; Couturier J; Tran-Perennou C; Schleiermacher G; Fehlbaum P; Doz F; Mosseri V; Delattre O; Klijanienko J; Vielh P; Michon J
    Pediatr Blood Cancer; 2007 Mar; 48(3):311-7. PubMed ID: 16609945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of drug resistance and protein kinase C genes in A2780 ovarian cancer cells after incubation with antineoplastic agents at sublethal concentrations.
    Brügger D; Brischwein K; Liu C; Bader P; Niethammer D; Gekeler V; Beck JF
    Anticancer Res; 2002; 22(6C):4229-32. PubMed ID: 12553062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P53 gene status in patients with advanced serous epithelial ovarian cancer in relation to response to paclitaxel- plus platinum-based chemotherapy and long-term clinical outcome.
    Gadducci A; Di Cristofano C; Zavaglia M; Giusti L; Menicagli M; Cosio S; Naccarato AG; Genazzani AR; Bevilacqua G; Cavazzana AO
    Anticancer Res; 2006; 26(1B):687-93. PubMed ID: 16739339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATP-binding cassette superfamily transporter gene expression in human primary ovarian carcinoma.
    Ohishi Y; Oda Y; Uchiumi T; Kobayashi H; Hirakawa T; Miyamoto S; Kinukawa N; Nakano H; Kuwano M; Tsuneyoshi M
    Clin Cancer Res; 2002 Dec; 8(12):3767-75. PubMed ID: 12473588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma.
    Arts HJ; Katsaros D; de Vries EG; Massobrio M; Genta F; Danese S; Arisio R; Scheper RJ; Kool M; Scheffer GL; Willemse PH; van der Zee AG; Suurmeijer AJ
    Clin Cancer Res; 1999 Oct; 5(10):2798-805. PubMed ID: 10537344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlations of EGFR and LRP to chemotherapy resistance and prognosis of ovarian cancer].
    Zhang J; Chen AP; Wang B; Zhao SP; Liu LZ; Dai SZ
    Ai Zheng; 2008 Dec; 27(12):1331-6. PubMed ID: 19080004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The expression of multiple drug resistance associated genes in ovarian cancer].
    Cheng G; Zhu H; Sun L
    Zhonghua Fu Chan Ke Za Zhi; 2000 Feb; 35(2):87-90. PubMed ID: 11809106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p21WAF1/CIP1 protein expression in primary ovarian cancer.
    Ferrandina G; Stoler A; Fagotti A; Fanfani F; Sacco R; De Pasqua A; Mancuso S; Scambia G
    Int J Oncol; 2000 Dec; 17(6):1231-5. PubMed ID: 11078810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of topoisomerase IIalpha (Topo IIalpha) and multidrug resistance-associated protein (MRP), plus chemosensitivity testing, as chemotherapeutic indices of ovarian and endometrial carcinomas.
    Koshiyama M; Fujii H; Kinezaki M; Morita Y; Nanno H; Yoshida M
    Anticancer Res; 2001; 21(4B):2925-32. PubMed ID: 11712788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and mutation of p53 in tumor effusion cells of patients with ovarian carcinoma: response to cisplatin-based chemotherapy.
    Bar JK; Harłozińska A; Popiela A; Noga L
    Tumour Biol; 2001; 22(2):83-91. PubMed ID: 11125280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of TGFß1 and its receptors is associated with biological features of ovarian cancer and sensitivity to paclitaxel/carboplatin.
    Komiyama S; Kurahashi T; Ishikawa M; Tanaka K; Komiyama M; Mikami M; Udagawa Y
    Oncol Rep; 2011 Apr; 25(4):1131-8. PubMed ID: 21249319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of lung resistance-related protein gene in transitional cell carcinoma of the bladder].
    Kong CZ; Zhu YY; Ma ZY; Liu DH; Zeng Y; Li ZL
    Zhonghua Wai Ke Za Zhi; 2005 Jan; 43(2):118-21. PubMed ID: 15771821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA expression of MDR1/P-glycoprotein, DNA-topoisomerase I, and MRP2 in ovarian carcinoma patients: correlation with chemotherapeutic response.
    Materna V; Pleger J; Hoffmann U; Lage H
    Gynecol Oncol; 2004 Jul; 94(1):152-60. PubMed ID: 15262134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung resistance-related protein (LRP) expression in malignant ascitic cells as a prognostic marker for advanced ovarian serous carcinoma.
    Kerr EH; Frederick PJ; Egger ME; Stockard CR; Sellers J; DellaManna D; Oelschlager DK; Amm HM; Eltoum IE; Straughn JM; Buchsbaum DJ; Grizzle WE; McNally LR
    Ann Surg Oncol; 2013 Sep; 20(9):3059-65. PubMed ID: 23525731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of proteins associated with multidrug resistance and resistance to chemotherapy in lung cancer].
    Paredes Lario A; Blanco García C; Echenique Elizondo M; Lobo C
    Arch Bronconeumol; 2007 Sep; 43(9):479-84. PubMed ID: 17919413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.